Rockwell Medical, Inc.
Head Quarters
30142 Wixom Road USWebsite
http://www.rockwellmed.comIndustry
MedicalSpecialtiesEmployees
300Exchange
NASDAQRockwell Medical, Inc. is a biopharmaceutical company, which engages in the targeting of end-stage renal disease and chronic kidney disease and manufactures innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. Its dialysis products include Triferic, Calcitriol Vitamin D Injection, Hemodialysis Concentrates, CitraPure, Dri-Sate, and ancillary products. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 7 |
| Gross Margin (%) | 0.13% |
| Net Margin (%) | -0.07% |
| Returns | Stock |
| Sales | $54.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$5.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 6.13 |
| EPS | $0.00 |